Acutus Medical Statistics
Share Statistics
Acutus Medical has 29.91M shares outstanding. The number of shares has increased by 1.62% in one year.
Shares Outstanding | 29.91M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0.19% |
Owned by Institutions (%) | n/a |
Shares Floating | 27.08M |
Failed to Deliver (FTD) Shares | 4.29K |
FTD / Avg. Volume | 2.07% |
Short Selling Information
The latest short interest is 553.60K, so 1.86% of the outstanding shares have been sold short.
Short Interest | 553.60K |
Short % of Shares Out | 1.86% |
Short % of Float | 2.04% |
Short Ratio (days to cover) | 0.68 |
Valuation Ratios
The PE ratio is -0.07 and the forward PE ratio is -0.03.
PE Ratio | -0.07 |
Forward PE | -0.03 |
PS Ratio | 0.82 |
Forward PS | 0 |
PB Ratio | -6.68 |
P/FCF Ratio | -0.09 |
PEG Ratio | n/a |
Enterprise Valuation
Acutus Medical Inc. has an Enterprise Value (EV) of 18.15M.
EV / Earnings | -0.22 |
EV / Sales | 2.53 |
EV / EBITDA | -1.35 |
EV / EBIT | -1.26 |
EV / FCF | -0.29 |
Financial Position
The company has a current ratio of 2.44, with a Debt / Equity ratio of -40.09.
Current Ratio | 2.44 |
Quick Ratio | 2.22 |
Debt / Equity | -40.09 |
Total Debt / Capitalization | 102.56 |
Cash Flow / Debt | -1.81 |
Interest Coverage | -2.54 |
Financial Efficiency
Return on equity (ROE) is 92.9% and return on capital (ROIC) is -38.4%.
Return on Equity (ROE) | 92.9% |
Return on Assets (ROA) | -1.51% |
Return on Capital (ROIC) | -38.4% |
Revenue Per Employee | 31.15K |
Profits Per Employee | -355.06K |
Employee Count | 230 |
Asset Turnover | 0.13 |
Inventory Turnover | 2.41 |
Taxes
Income Tax | 63.00K |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -72.79% in the last 52 weeks. The beta is 0.01, so Acutus Medical 's price volatility has been higher than the market average.
Beta | 0.01 |
52-Week Price Change | -72.79% |
50-Day Moving Average | 0.11 |
200-Day Moving Average | 0.09 |
Relative Strength Index (RSI) | 39.93 |
Average Volume (20 Days) | 207.09K |
Income Statement
In the last 12 months, Acutus Medical had revenue of $7.16M and earned -$81.66M in profits. Earnings per share was $-2.81.
Revenue | 7.16M |
Gross Profit | -3.14M |
Operating Income | -14.36M |
Net Income | -81.66M |
EBITDA | -13.49M |
EBIT | -14.36M |
Earnings Per Share (EPS) | -2.81 |
Balance Sheet
The company has $19.17M in cash and $38.48M in debt, giving a net cash position of -$19.31M.
Cash & Cash Equivalents | 19.17M |
Total Debt | 38.48M |
Net Cash | -19.31M |
Retained Earnings | -599.98M |
Total Assets | 32.17M |
Working Capital | 12.49M |
Cash Flow
In the last 12 months, operating cash flow was -$63.61M and capital expenditures -$219.00K, giving a free cash flow of -$63.34M.
Operating Cash Flow | -63.61M |
Capital Expenditures | -219.00K |
Free Cash Flow | -63.34M |
FCF Per Share | -2.18 |
Margins
Gross margin is -43.79%, with operating and profit margins of -200.46% and -1.14K%.
Gross Margin | -43.79% |
Operating Margin | -200.46% |
Pretax Margin | -165.52% |
Profit Margin | -1.14K% |
EBITDA Margin | -188.26% |
EBIT Margin | -200.46% |
FCF Margin | -884.1% |
Dividends & Yields
AFIB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -4683.33% |
FCF Yield | -3471.19% |
Analyst Forecast
Currently there are no analyst rating for AFIB.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -22.02 |
Piotroski F-Score | 3 |